ImmuCell (ICCC) Short Interest Ratio & Short Volume $5.02 +0.01 (+0.20%) Closing price 02/21/2025 03:58 PM EasternExtended Trading$4.94 -0.08 (-1.59%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ImmuCell Short Interest DataImmuCell (ICCC) has a short interest of 15,500 shares, representing 0.27% of the float (the number of shares available for trading by the public). This marks a -1.90% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 3,981 shares to cover all short positions.Current Short Interest15,500 sharesPrevious Short Interest15,800 sharesChange Vs. Previous Month-1.90%Dollar Volume Sold Short$83,545.00Short Interest Ratio1.2 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares8,910,000 sharesFloat Size5,740,000 sharesShort Percent of Float0.27%Today's Trading Volume3,235 sharesAverage Trading Volume3,981 sharesToday's Volume Vs. Average81% Short Selling ImmuCell? Sign up to receive the latest short interest report for ImmuCell and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartICCC Short Interest Over TimeICCC Days to Cover Over TimeICCC Percentage of Float Shorted Over Time ImmuCell Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202515,500 shares $83,545.00 -1.9%0.3%1.2 $5.39 1/15/202515,800 shares $83,582.00 -3.7%0.3%1 $5.29 12/31/202416,400 shares $84,460.00 +24.2%0.3%0.9 $5.15 12/15/202413,200 shares $64,944.00 -14.8%0.2%0.7 $4.92 11/30/202415,500 shares $63,860.00 -34.3%0.3%0.7 $4.12 11/15/202423,600 shares $85,196.00 +490.0%0.4%0.7 $3.61 10/31/20244,000 shares $14,440.00 -51.2%0.1%0.1 $3.61 10/15/20248,200 shares $29,110.00 -29.9%0.2%0.2 $3.55 9/30/202411,700 shares $42,471.00 +37.7%0.3%0.3 $3.63 9/15/20248,500 shares $30,855.00 -54.3%0.2%0.2 $3.63 Get the Latest News and Ratings for ICCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmuCell and its competitors with MarketBeat's FREE daily newsletter. 8/31/202418,600 shares $69,564.00 +644.0%0.4%0.6 $3.74 8/15/20242,500 shares $9,225.00 -40.5%0.0%0.1 $3.69 7/31/20244,200 shares $17,052.00 +5.0%0.1%0.4 $4.06 7/15/20244,000 shares $16,960.00 -29.8%0.1%0.4 $4.24 6/30/20245,700 shares $27,645.00 -12.3%0.1%0.5 $4.85 6/15/20246,500 shares $27,170.00 +30.0%0.1%0.5 $4.18 5/31/20245,000 shares $21,250.00 +66.7%0.1%0.4 $4.25 5/15/20243,000 shares $14,640.00 -41.2%0.1%0.3 $4.88 4/30/20245,100 shares $25,041.00 +13.3%0.1%0.6 $4.91 4/15/20244,500 shares $22,725.00 -26.2%0.1%0.6 $5.05 3/31/20246,100 shares $32,330.00 -4.7%0.1%0.8 $5.30 3/15/20246,400 shares $33,600.00 +1.6%0.1%0.8 $5.25 2/29/20246,300 shares $33,075.00 -20.3%0.1%0.8 $5.25 2/15/20247,900 shares $39,697.50 +5.3%0.1%0.9 $5.03 1/31/20247,500 shares $39,825.00 -2.6%0.1%0.8 $5.31 1/15/20247,700 shares $39,347.00 -13.5%0.1%0.6 $5.11 12/31/20238,900 shares $45,301.00 +30.9%0.2%0.8 $5.09 12/15/20236,800 shares $31,144.00 +13.3%0.1%0.5 $4.58 11/30/20236,000 shares $27,240.00 -7.7%0.1%0.4 $4.54 11/15/20236,500 shares $32,825.00 -52.2%0.1%0.4 $5.05 10/31/202313,600 shares $68,680.00 +70.0%0.3%0.8 $5.05 10/15/20238,000 shares $40,160.00 -28.6%0.1%0.5 $5.02 9/30/202311,200 shares $59,806.88 +62.3%0.2%0.7 $5.34 9/15/20236,900 shares $36,984.00 +15.0%0.1%0.4 $5.36 8/31/20236,000 shares $27,660.00 No Change0.1%0.4 $4.61 8/15/20236,000 shares $29,700.00 -11.8%0.1%0.5 $4.95 7/31/20236,800 shares $36,924.00 +11.5%0.1%0.6 $5.43 7/15/20236,100 shares $31,049.00 -3.2%0.1%0.6 $5.09 6/30/20236,300 shares $31,500.00 No Change0.1%0.7 $5.00 6/15/20236,300 shares $34,713.00 -6.0%0.1%0.8 $5.51Has Trump finally met his match? (Ad)Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?Click here for his emergency broadcast... 5/31/20236,700 shares $31,959.00 -30.2%0.1%0.8 $4.77 5/15/20239,600 shares $47,712.00 No Change0.2%1.1 $4.97 10/31/202210,500 shares $84,105.00 -38.2%0.2%1.3 $8.01 10/15/202217,000 shares $133,620.00 +60.4%0.3%2 $7.86 9/30/202210,600 shares $79,288.00 +6.0%0.2%1.2 $7.48 9/15/202210,000 shares $75,700.00 +19.1%0.2%1.1 $7.57 8/31/20228,400 shares $61,236.00 +12.0%0.2%0.9 $7.29 8/15/20227,500 shares $60,450.00 -24.2%0.1%1 $8.06 7/31/20229,900 shares $86,922.00 +32.0%0.2%1.1 $8.78 7/15/20227,500 shares $63,000.00 -13.8%0.1%0.7 $8.40 6/30/20228,700 shares $75,603.00 +24.3%0.2%0.8 $8.69 6/15/20227,000 shares $56,840.00 +1.5%0.1%0.6 $8.12 5/31/20226,900 shares $55,959.00 No Change0.1%0.6 $8.11 5/15/20226,900 shares $55,959.00 -45.2%0.1%0.6 $8.11 4/30/202212,600 shares $122,724.00 +41.6%0.2%1.1 $9.74 4/15/20228,900 shares $79,655.00 -22.6%0.2%0.8 $8.95 3/31/202211,500 shares $110,975.00 +21.1%N/A1.1 $9.65 3/15/20229,500 shares $82,270.00 +50.8%0.2%0.9 $8.66 2/28/20226,300 shares $51,471.00 -24.1%0.1%0.6 $8.17 2/15/20228,300 shares $68,226.00 +38.3%0.2%0.7 $8.22 1/31/20226,000 shares $48,900.00 -31.0%0.1%0.5 $8.15 1/15/20228,700 shares $76,617.42 +11.5%N/A0 $8.81 12/31/20217,800 shares $62,400.00 +39.3%0.1%1 $8.00 12/15/20215,600 shares $47,824.00 -35.6%0.1%0.8 $8.54 11/30/20218,700 shares $77,691.00 +13.0%0.2%1.5 $8.93 11/15/20217,700 shares $70,840.00 -10.5%0.1%1.2 $9.20 10/29/20218,600 shares $75,680.00 +24.6%0.2%1.1 $8.80 10/15/20216,900 shares $64,032.00 -33.7%0.1%0.9 $9.28 9/30/202110,400 shares $97,344.00 -3.7%0.2%0.8 $9.36 9/15/202110,800 shares $99,252.00 -12.9%0.2%0.8 $9.19 8/31/202112,400 shares $113,584.00 -29.1%0.2%0.9 $9.16 8/13/202117,500 shares $157,675.00 +7.4%0.3%1.4 $9.01 7/30/202116,300 shares $164,141.00 +109.0%0.3%1.1 $10.07 7/15/20217,800 shares $70,200.00 -25.7%0.1%0.5 $9.00 6/30/202110,500 shares $99,750.00 +15.4%0.2%0.8 $9.50 6/15/20219,100 shares $89,553.10 -37.7%0.2%0.7 $9.84 5/28/202114,600 shares $142,642.00 +31.5%0.3%1 $9.77 5/14/202111,100 shares $102,231.00 -11.9%0.2%0.6 $9.21 4/30/202112,600 shares $128,646.00 +46.5%0.2%0.5 $10.21 4/15/20218,600 shares $79,636.00 +28.4%N/A0 $9.26 3/31/20216,700 shares $62,645.00 +19.6%0.1%0.1 $9.35 3/15/20215,600 shares $60,312.00 -5.1%0.1%0.1 $10.77 2/26/20215,900 shares $62,776.00 -10.6%0.1%0.1 $10.64 2/12/20216,600 shares $74,382.00 -14.3%0.1%0.1 $11.27 1/29/20217,700 shares $57,365.00 +63.8%0.2%0.2 $7.45 1/15/20214,700 shares $29,586.50 +14.6%0.1%0.4 $6.30 12/31/20204,100 shares $24,559.00 -28.1%0.1%0.4 $5.99 12/15/20205,700 shares $36,423.00 +67.7%0.1%0.7 $6.39 11/30/20203,400 shares $20,400.00 -5.6%0.1%0.4 $6.00 11/15/20203,600 shares $20,700.00 +50.0%0.1%0.4 $5.75Has Trump finally met his match? (Ad)Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?Click here for his emergency broadcast... 10/30/20202,400 shares $12,504.00 -74.5%0.1%0.3 $5.21 10/15/20209,400 shares $52,828.00 -42.0%0.2%0.9 $5.62 9/30/202016,200 shares $87,966.00 -3.6%0.3%1.4 $5.43 9/15/202016,800 shares $88,032.00 +162.5%0.3%1 $5.24 8/31/20206,400 shares $33,408.00 -46.2%0.1%0.3 $5.22 8/14/202011,900 shares $66,878.00 -56.7%0.2%0.5 $5.62 7/31/202027,500 shares $136,950.00 +32.9%0.5%0.9 $4.98 7/15/202020,700 shares $125,235.00 +38.9%0.4%0.7 $6.05 6/30/202014,900 shares $71,669.00 +254.8%0.3%0.5 $4.81 6/15/20204,200 shares $17,808.00 +223.1%0.1%0.2 $4.24 5/29/20201,300 shares $5,824.00 -90.3%0.0%0 $4.48 5/15/202013,400 shares $54,404.00 -39.6%0.3%0.4 $4.06 4/30/202022,200 shares $101,498.40 -31.9%0.4%0.8 $4.57 4/15/202032,600 shares $138,550.00 -24.7%0.6%0.7 $4.25 3/31/202043,300 shares $202,644.00 -7.1%0.8%0.5 $4.68 3/13/202046,600 shares $195,254.00 +55.3%0.9%0.9 $4.19 2/28/202030,000 shares $138,000.00 +25.0%0.6%0.4 $4.60 ICCC Short Interest - Frequently Asked Questions What is ImmuCell's current short interest? Short interest is the volume of ImmuCell shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 15,500 shares of ICCC short. 0.27% of ImmuCell's shares are currently sold short. Learn More on ImmuCell's current short interest. What is a good short interest ratio for ImmuCell? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ICCC shares currently have a short interest ratio of 1.0. Learn More on ImmuCell's short interest ratio. What is a good short interest percentage for ImmuCell? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.27% of ImmuCell's floating shares are currently sold short. Is ImmuCell's short interest increasing or decreasing? ImmuCell saw a decrease in short interest during the month of January. As of January 31st, there was short interest totaling 15,500 shares, a decrease of 1.9% from the previous total of 15,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ImmuCell's float size? ImmuCell currently has issued a total of 8,910,000 shares. Some of ImmuCell's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ImmuCell currently has a public float of 5,740,000 shares. How does ImmuCell's short interest compare to its competitors? 0.27% of ImmuCell's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ImmuCell: Lyell Immunopharma, Inc. (7.64%), Zentalis Pharmaceuticals, Inc. (6.81%), CARGO Therapeutics, Inc. (18.87%), Vaxart, Inc. (4.88%), Acrivon Therapeutics, Inc. (5.01%), Cidara Therapeutics, Inc. (2.97%), Alector, Inc. (7.25%), Aclaris Therapeutics, Inc. (5.49%), Greenwich LifeSciences, Inc. (10.90%), Innate Pharma S.A. (0.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short ImmuCell stock? Short selling ICCC is an investing strategy that aims to generate trading profit from ImmuCell as its price is falling. ICCC shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ImmuCell? A short squeeze for ImmuCell occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ICCC, which in turn drives the price of the stock up even further. How often is ImmuCell's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ICCC, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies LYEL Short Squeeze ZNTL Short Squeeze CRGX Short Squeeze VXRT Short Squeeze ACRV Short Squeeze CDTX Short Squeeze ALEC Short Squeeze ACRS Short Squeeze GLSI Short Squeeze IPHA Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ICCC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmuCell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmuCell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
